Xvivo Perfusion AB
STO:XVIVO
Xvivo Perfusion AB
Cash from Financing Activities
Xvivo Perfusion AB
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Xvivo Perfusion AB
STO:XVIVO
|
Cash from Financing Activities
kr418.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
87%
|
CAGR 10-Years
43%
|
|
Bactiguard Holding AB
STO:BACTI B
|
Cash from Financing Activities
-kr13.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
See Also
What is Xvivo Perfusion AB's Cash from Financing Activities?
Cash from Financing Activities
418.7m
SEK
Based on the financial report for Mar 31, 2024, Xvivo Perfusion AB's Cash from Financing Activities amounts to 418.7m SEK.
What is Xvivo Perfusion AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
43%
The average annual Cash from Financing Activities growth rates for Xvivo Perfusion AB have been -5% over the past three years , 87% over the past five years , and 43% over the past ten years .